Cannabidiol

Cannabidiol
Product Description

Pharma Grade Cannabidiol API

  • Produced by chemical synthesis;
  • Quality attributes, residual solvents and elemental impurities and in accordance with the ICH guidelines;
  • Organic impurities (including delta-9-THC and delta-8-THC) bellow to 0.06% (complies for 1750 mg maximum daily dose, according to ICH Q3A(R2));
  • Storage condition: up to 30oC (stability studies are being conducted in order to address climatic zones I and II, as well as IVB, in accordance with ICH Q1A and ICH Q1B guidelines).
  • DMF prepared in accordance with the M4Q guideline;
  • Technical support for drug product development

Read more Show less

Prati, Donaduzzi & Cia Ltda

  • Country/Region:
    Brazil
  • On CPHI since:
    2019
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    13956-29-1
More specifications Fewer specifications

Prati, Donaduzzi & Cia Ltda

  • Country/Region:
    Brazil
  • On CPHI since:
    2019
View company profile

More Products from Prati, Donaduzzi & Cia Ltda (2)

  • Cannabidiol oral solution 200mg/mL

    Product Cannabidiol oral solution 200mg/mL

    Product description:
    • Commercial name: Myalo • Indication: Refractory epilepsy • THC FREE • Clinical studies phase III - https://clinicaltrials.gov/ct2/show/NCT02783092?term=prati&rank=1 • Pharmaceutical grade • No interconversion "in vivo" THC • Ora...
  • CBD

    Product CBD

    Pharma Grade CBD API • Produced by chemical synthesis; • Quality attributes, residual solvents and elemental impurities and in accordance with the ICH guidelines; • Organic impurities (including delta-9-THC and delta-8-THC) bellow to 0.06% (complies for 1750 m...